BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11317524)

  • 1. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(2):175-80. PubMed ID: 11317524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):65-70. PubMed ID: 11286132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):71-6. PubMed ID: 11286133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(6B):4585-90. PubMed ID: 11210857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2001; 21(3B):2021-8. PubMed ID: 11497292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase expression in childhood astrocytomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(5A):3287-92. PubMed ID: 11062755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):667-73. PubMed ID: 11212844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy.
    Pritchard SC; Nicolson MC; Lloret C; McKay JA; Ross VG; Kerr KM; Murray GI; McLeod HL
    Oncol Rep; 2001; 8(2):421-4. PubMed ID: 11182067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
    Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
    J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
    Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
    Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.